362 related articles for article (PubMed ID: 34479635)
1. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.
Xiong LY; Ouk M; Wu CY; Rabin JS; Lanctôt KL; Herrmann N; Black SE; Edwards JD; Swardfager W
Alzheimers Res Ther; 2021 Sep; 13(1):147. PubMed ID: 34479635
[TBL] [Abstract][Full Text] [Related]
2. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
3. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
4. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease.
Ciafone J; Thomas A; Durcan R; Donaghy PC; Hamilton CA; Lawley S; Roberts G; Colloby S; Firbank MJ; Allan L; Petrides G; Taylor JP; O'Brien JT; Gallagher P
J Int Neuropsychol Soc; 2022 Oct; 28(9):963-973. PubMed ID: 34666864
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
[TBL] [Abstract][Full Text] [Related]
7. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of cognitive decline in different domains prior to AD onset in persons with mild cognitive impairment.
Yuan M; Rong M; Long X; Lian S; Fang Y
Arch Gerontol Geriatr; 2024 Jul; 122():105375. PubMed ID: 38431989
[TBL] [Abstract][Full Text] [Related]
9. Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study.
Gupta A; Mahnken JD; Bernal J; Sharma P; Lepping RJ; Montgomery RN; Johnson DK; Parks A; Burns JM; Drew DA; Sarnak MJ; Brooks WM
Am J Kidney Dis; 2024 Jul; 84(1):28-37.e1. PubMed ID: 38423160
[TBL] [Abstract][Full Text] [Related]
10. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
Morris JC
Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
15. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
18. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
[TBL] [Abstract][Full Text] [Related]
19. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
Park SJ; Lee JE; Lee KS; Kim JS
Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
